e480 bidity. Up to 40% of patients may suffer a recurrent event in their first 10 years after
diagnosis despite initial effective blood-thinning treatment, necessitating life-long therapy …

This first “Call to Action to Prevent Deep Vein Thrombosis (DVT) and Pulmonary Embolism
(PE),” provides vital information on critical health problems that cause enormous health …

Every year, an estimated 200,000 up to 600,000 Americans will suffer from deep-vein
thrombosis (DVT) and pulmonary embolism (PE). 1, 2, 3 Deep-vein thrombosis and PE are …

Deep vein thrombosis (DVT) represents a significant burden of disease in North America. 1–
3 The long-term sequela of DVT is the post-thrombotic syndrome, characterized by chronic …

Foreword This Journal feature begins with a case vignette highlighting a common clinical
problem. Evidence supporting various strategies is then presented, followed by a review of …

Venous thromboembolic disease is the third most common cardiovascular disease after
atherosclerotic heart disease and stroke. It has been estimated that between 500,000 and …

In May 2006, former US Surgeon General Richard H. Carmona, in conjunction with the
National Heart Lung and Blood Institute, hosted the Surgeon General's Workshop on Deep …

Deep venous thrombosis (DVT) refers to occlusion within the venous system, most
commonly of the lower extremities, which can lead to pulmonary embolism (PE), or …

Venous thromboembolism (VTE) is the third most common cardiovascular disorder, affecting
up to 5% of the population. VTE commonly manifests as lower-extremity deep venous …

Venous thromboembolism (VTE, ie, deep vein thrombosis [DVT] or pulmonary embolism
[PE]) is a common complication affecting approximately 25% of all hospitalized patients. The …